Dermata Therapeutics, Inc. - Common Stock (DRMA)
1.2570
+0.0170 (1.37%)
Dermata Therapeutics Inc is a biotechnology company focused on developing innovative therapeutics for skin diseases and conditions
The company leverages its proprietary technology platform to create treatments that aim to improve patient outcomes in dermatology. Dermata Therapeutics is committed to addressing unmet medical needs and advancing its product candidates through various stages of clinical development. By prioritizing research and development, the company seeks to bring forward effective solutions for skin health and enhance the quality of life for individuals affected by dermatological disorders.
Frequently Asked Questions
Is Dermata Therapeutics, Inc. - Common Stock publicly traded?
Yes, Dermata Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Dermata Therapeutics, Inc. - Common Stock trade on?
Dermata Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Dermata Therapeutics, Inc. - Common Stock?
The ticker symbol for Dermata Therapeutics, Inc. - Common Stock is DRMA on the Nasdaq Stock Market
What is the current price of Dermata Therapeutics, Inc. - Common Stock?
The current price of Dermata Therapeutics, Inc. - Common Stock is 1.257
When was Dermata Therapeutics, Inc. - Common Stock last traded?
The last trade of Dermata Therapeutics, Inc. - Common Stock was at 1:09 pm EDT on March 24th, 2025